全文获取类型
收费全文 | 976篇 |
免费 | 58篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 58篇 |
妇产科学 | 5篇 |
基础医学 | 281篇 |
口腔科学 | 27篇 |
临床医学 | 72篇 |
内科学 | 206篇 |
皮肤病学 | 52篇 |
神经病学 | 42篇 |
特种医学 | 23篇 |
外科学 | 97篇 |
综合类 | 2篇 |
预防医学 | 35篇 |
眼科学 | 3篇 |
药学 | 64篇 |
中国医学 | 17篇 |
肿瘤学 | 48篇 |
出版年
2022年 | 11篇 |
2021年 | 13篇 |
2020年 | 3篇 |
2019年 | 9篇 |
2018年 | 12篇 |
2017年 | 10篇 |
2016年 | 23篇 |
2015年 | 19篇 |
2014年 | 30篇 |
2013年 | 28篇 |
2012年 | 63篇 |
2011年 | 54篇 |
2010年 | 37篇 |
2009年 | 33篇 |
2008年 | 60篇 |
2007年 | 66篇 |
2006年 | 70篇 |
2005年 | 80篇 |
2004年 | 76篇 |
2003年 | 72篇 |
2002年 | 66篇 |
2001年 | 23篇 |
2000年 | 14篇 |
1999年 | 13篇 |
1998年 | 19篇 |
1997年 | 8篇 |
1996年 | 9篇 |
1995年 | 15篇 |
1994年 | 4篇 |
1992年 | 7篇 |
1991年 | 4篇 |
1990年 | 6篇 |
1989年 | 3篇 |
1986年 | 4篇 |
1985年 | 3篇 |
1984年 | 3篇 |
1979年 | 3篇 |
1976年 | 4篇 |
1975年 | 2篇 |
1974年 | 3篇 |
1973年 | 5篇 |
1972年 | 3篇 |
1969年 | 2篇 |
1965年 | 3篇 |
1961年 | 2篇 |
1956年 | 2篇 |
1939年 | 3篇 |
1928年 | 3篇 |
1911年 | 2篇 |
1908年 | 3篇 |
排序方式: 共有1037条查询结果,搜索用时 15 毫秒
21.
22.
Rainer P Woitas Bodo Stoschus Birgit Terjung Martin Vogel Bernd Kupfer Hans H Brackmann Jürgen K Rockstroh Tilman Sauerbruch Ulrich Spengler 《Liver international》2005,25(6):1114-1121
Background: Hepatitis C virus (HCV) infection is associated with multiple extrahepatic manifestations. It is unclear to what extent extrahepatic manifestations occur in HIV/HCV coinfection. Methods: We prospectively assessed cross-sectional frequencies of autoimmune manifestations in HIV/HCV-coinfected patients (n=98), HIV-mono-infected (n=45) and HCV-mono-infected patients (n=78). Diagnostic vasculitis scores, HCV and HIV loads, CD4 cell counts, thyroid-, cardiolipin-, non-organ-specific tissue antibodies (nuclear, smooth muscle, anti-liver-kidney-microsome, neutrophil-cytoplasmic) and cryoglobulins were determined. Results: Synergistic effects of HCV and HIV infection were observed with respect to the prevalence of antibodies against thyroglobulin (HCV infection 15.4%, HIV infection 8.8%, HIV/HCV coinfection 30.6%; P<0.001) and cardiolipin antibodies (HCV infection 9.0%, HIV infection 31%, HIV/HCV coinfection 46%; P<0.001). Cryoglobulinemia type III, was significantly associated with HCV infection (HCV, 25.6%; HIV/HCV, 20.4%) but not with HIV infection (4.4%, P<0.05). Rheumatoid factor was commonly detected in patients with HCV infection (48%), but occurred considerably less frequently in patients with HIV infection (4.4%) or HIV/HCV coinfection (9.5%, P<0.01). Conclusion: HIV coinfection appears to differentially modulate the frequency of HCV-related autoimmunity. However, autoimmunity is rarely accompanied by clinical manifestations. 相似文献
23.
Etiologies for human hypogammaglobulinemias are diverse and include genetic and nongenetic causes. Although recent reviews
focus on the complex genetics of common variable immunodeficiency, in this review, we survey different causes of hypogammaglobulinemias
and discuss possible mechanisms. 相似文献
24.
25.
26.
PATHOPHYSIOLOGY AND THERAPY: Left ventricular hypertrophy represents an important factor determining the prognosis of hypertensive patients. Hypertrophy as identified by electrocardiography (Table 1) or echocardiography (Table 2) characterizes patients with a significantly increased risk of mortality and arrhythmia. From the pathophysiological point of view this is based on hypertrophy of the media in resistance vessels, on interstitial fibrosis, on a reduced coronary flow reserve and on the occurrence of ischemia (Figure 1). The diastolic and (later) systolic function of the heart are disturbed (Figures 2 to 4). Antihypertensive therapy with beta blockers and diuretics leads to a reduction of left ventricular mass by 5-8%, with ACE-inhibitors and AT-blockers by 13% (Figure 5). Particularly ACE-inhibitors can effectively reverse of the above mentioned pathological processes. Regression of hypertrophy goes along with an improved prognosis and a reduction of atrial and ventricular arrhythmias (Figure 6). A symptomatic treatment of arrhythmias should always be accompanied by medical therapy aimed at regression of hypertrophy. Optimal therapy results in normalizes of blood pressure, leads to a regression of hypertrophy and induces cardiac reparation, which in turn improve left ventricular function, reduces microvascular ischemia stress and arrhythmias. These therapeutic desiderates are also pertinent for hypertensive heart disease in the prehypertrophic state, as in juvenile hypertension. 相似文献
27.
F. S. Liotti A. R. Menghini P. Guerrieri V. Talesa M. Bodo 《Journal of cancer research and clinical oncology》1984,108(2):230-232
Summary The effects of AA and DHA on ATP C+ cell multiplication in vitro were studied by measuring incorporation of 3H thymidine into DNA. The results obtained demonstrate that both AA and DHA have the same effects: they favor cell multiplication at low doses and inhibit it at high doses. Experiments carried out with serial doses of both these substances revealed that AA is more efficient in determining both stimulating and inhibiting effects. The lesser efficiency of DHA may be attributed to its limited stability in culture medium. Studies on the effect of high doses of AA and DHA added to the culture medium in single or fractionated doses revealed that fractionated administration is more efficient in inhibiting cell multiplication than single administration.Abbreviations AA
ascorbic acid
- DHA
dehydroascorbic acid
- ATP C+
ascites tumor Perugia in Balb C+ mice
- GSH
reduced glutathione 相似文献
28.
Flavonoid quercetin, but not apigenin or luteolin, induced apoptosis in human myeloid leukemia cells and their resistant variants 总被引:1,自引:0,他引:1
Flavonoids and their in vivo metabolites are neuroprotective, cardioprotective and chemopreventive agents acting as hydrogen-donating antioxidants or modulators functioning at protein kinase and lipid signaling pathways. In presented study treatments of human leukemia cells HL60 and their MDR-1 resistant subline HL60/VCR by flavonoids apigenin (API), luteolin (LUT), quercetin (QU) and anticancer drug doxorubicin (DOX) are reported. Of all flavonoids used only QU treatments led in both cell lines to DNA fragmentation, cleavage of poly (ADP- ribose) polymerase (PARP), up-regulation of proapoptotic Bax and posttranslational modification (phosphorylation) of antiapoptotic Bcl-2. Cytochrome c and p21WAF1/CIP1 levels remained unchanged in these cells. Furthermore, treatments of both cell lines by QU and in its combined application with DOX increased phosphorylation of ERK, while Akt-1 and phosphorylated Akt-1 levels were not changed. All these events resulted in effective induction of apoptosis associated with down-regulation of P-glycoprotein in resistant cells. Presented results suggest that in human leukemia cells QU is a potent regulator of the cell apoptotic program associated with the modulation of several signaling molecules. 相似文献
29.
A prospective study on incidence and risk factors of arteriovenous fistulae following transfemoral cardiac catheterization 总被引:4,自引:0,他引:4
BACKGROUND: A potentially harmful complication of cardiac catheterization is the arteriovenous fistula. Precise knowledge of possible factors predisposing for acquisition of iatrogenic AV-fistulae could enable cardiologists to perform a risk stratification for cardiac patients prior to catheterization. METHODS: Over a period of 2 years, 10,271 consecutive patients who underwent cardiac catheterization were included in this study. Auscultation of a new femoral bruit was followed by a duplex scan to confirm the suspected diagnosis of an AVF. Every patient was investigated on the day after catheterization. RESULTS: The incidence of iatrogenic AVF was 0.86%. A multivariate regression analysis revealed five significant and independent risk factors: (1) procedural heparin dosage >or=12,500 IU (Odds Ratio (OR)=2.88), (2) coumadin therapy (OR=2.34), (3) puncture of the left groin (OR=2.21), (4) arterial hypertension (OR=1.86) and (5) female gender (OR=1.84). Coronary angioplasty (instead of diagnostic procedure), size and number of sheaths, age and body mass index did not significantly affect the incidence of AVF. CONCLUSIONS: The overall incidence of AV-fistulae following cardiac catheterization approximates 1%. Determination of significant risk factors will facilitate identification of patients at risk for iatrogenic arteriovenous fistulae prior to cardiac catheterization and thus help to develop strategies to reduce the incidence of AV-fistulae. 相似文献
30.